Q&A 179: recurrent multi-drug resistant UTIs on an anti-CD20 therapy

As your MS appears to be getting worse without obvious relapses or new MRI activity, you likely have smouldering MS and may become eligible for tolebrutinib when it gets licensed and reimbursed.